iodixanol and regorafenib

iodixanol has been researched along with regorafenib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersen, IR; Boysen, AK; Jensen, LH; Mortensen, FV; Nielsen, DT; Olesen, R; Rasmussen, F	1

Other Studies

1 other study(ies) available for iodixanol and regorafenib

Article	Year
Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic colorectal cancer treated with regorafenib. Acta radiologica (Stockholm, Sweden : 1987), 2019, Volume: 60, Issue:7 Topics: Abdominal Neoplasms; Aged; Biomarkers; Colorectal Neoplasms; Contrast Media; Female; Four-Dimensional Computed Tomography; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Phenylurea Compounds; Pyridines; Radiographic Image Enhancement; Response Evaluation Criteria in Solid Tumors; Treatment Outcome; Triiodobenzoic Acids	2019

Article

Year

Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic colorectal cancer treated with regorafenib.

Acta radiologica (Stockholm, Sweden : 1987), 2019, Volume: 60, Issue:7

Topics: Abdominal Neoplasms; Aged; Biomarkers; Colorectal Neoplasms; Contrast Media; Female; Four-Dimensional Computed Tomography; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Phenylurea Compounds; Pyridines; Radiographic Image Enhancement; Response Evaluation Criteria in Solid Tumors; Treatment Outcome; Triiodobenzoic Acids

2019